Therefore, we conduct this large population-based study to examine whether very early T stage in the context of serum CEA elevation may be a surrogate for biologically aggressive disease and predict for poor cause-specific survival (CSS) of rectal cancer. This evidence concerns the gene CEACAM5 and rectal cancer.